Patents by Inventor Barry Byrne

Barry Byrne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110034676
    Abstract: A method of generating and isolating a recombinant high affinity anti-sialic acid antibody molecule comprises the steps of immunising a host with an immunogen comprising a conjugate of sialic acid and a carrier protein to generate an anti-sialic acid polyclonal serum, isolating a sample of RNA from the immunised avian host, and generating and screening of a library of recombinant antibody molecules from the RNA sample, and isolating a recombinant high affinity anti-sialic acid antibody molecule. The antibody molecule is selected from the group consisting of: whole antibodies; scFv fragments; and Fab fragments, and the host is Gallus domesticus. A recombinant avian antibody fragment having high binding affinity to sialic acid and obtainable by the method of the invention, and an anti-sialic acid polyclonal serum obtainable by immunising an avian host with a conjugate of sialic acid and carrier protein, are also described.
    Type: Application
    Filed: August 6, 2010
    Publication date: February 10, 2011
    Applicant: DUBLIN CITY UNIVERSITY
    Inventors: Gerard Gary Donohoe, Barry Byrne, Stephen Henry Hearty, Richard O'Kennedy
  • Patent number: 7356833
    Abstract: A method and system for automatically and transparently providing access to resources associated with a web server which requires authentication. A server is provided for a web browser, which intercepts and responds to authentication requests from web servers. The method and system allows a user to access multiple network resources with a single initial authentication procedure.
    Type: Grant
    Filed: August 13, 2003
    Date of Patent: April 8, 2008
    Assignee: Computer Associates Think, Inc.
    Inventor: Barry A. Byrne
  • Publication number: 20080069803
    Abstract: The use of recombinant adeno-associated virus (AAV) virions for delivery of DNA molecules to muscle cells and tissue is disclosed. The invention allows for the direct, in vivo injection of recombinant AAV virions into muscle tissue, e.g., by intramuscular injection, as well as for the in vitro transduction of muscle cells which can subsequently be introduced into a subject for treatment. The invention provides for sustained, high-level expression of the delivered gene and for in vivo secretion of the therapeutic protein from transduced muscle cells such that systemic delivery is achieved.
    Type: Application
    Filed: October 30, 2007
    Publication date: March 20, 2008
    Inventors: Gregory Podsakoff, Paul Kessler, Barry Byrne, Gary Kurtzman
  • Publication number: 20070015238
    Abstract: Vectors that encode Adeno-Associated Virus (AAV) Rep and Cap proteins of different serotypes and Adenovirus transcription products that provide helper functions were used to produce pseudotyped recombinant AAV (rAAV) virions. Purification methods generated pseudotyped rAAV virion stocks that were 99% pure with titers of 1×1012?1×1013 vector genomes/ml.
    Type: Application
    Filed: June 5, 2003
    Publication date: January 18, 2007
    Inventors: Richard Snyder, Sergie Zolotukhin, Yoshihisa Sakai, Barry Byrne, Mark Potter, Irine Zolotukhin, Scott Loiler, Vince Chiodo, Nicholas Muzyczka, William Hauswirth, Terence Flotte, Corinna Burger, Edgardo Rodriguez
  • Publication number: 20060099184
    Abstract: The use of recombinant adeno-associated virus (AAV) virions for delivery of DNA molecules to muscle cells and tissue is disclosed. The invention allows for the direct, in vivo injection of recombinant AAV virions into muscle tissue, e.g., by intramuscular injection, as well as for the in vitro transduction of muscle cells which can subsequently be introduced into a subject for treatment. The invention provides for sustained, high-level expression of the delivered gene and for in vivo secretion of the therapeutic protein from transduced muscle cells such that systemic delivery is achieved.
    Type: Application
    Filed: December 15, 2005
    Publication date: May 11, 2006
    Inventors: Gregory Podsakoff, Paul Kessler, Barry Byrne, Gary Kurtzman
  • Publication number: 20060078542
    Abstract: Disclosed are water-soluble gel-based compositions for the delivery of recombinant adeno-associated virus (rAAV) vectors that express nucleic acid segments encoding therapeutic constructs including peptides, polypeptides, ribozymes, and catalytic RNA molecules, to selected cells and tissues of vertebrate animals. Also disclosed are gel-based rAAV compositions are useful in the treatment of mammalian, and in particular, human diseases, including for example, cardiac disease or dysfunction, and musculoskeletal disorders and congenital myopathies, including, for example, muscular dystrophy, acid maltase deficiency (Pompe's disease), and the like. In illustrative embodiments, the invention provides rAAV vectors comprised within a biocompatible gel composition for enhanced viral delivery/transfection to mammalian tissues, and in particular to vertebrate muscle tissues such as a human heart or diaphragm tissue.
    Type: Application
    Filed: February 10, 2005
    Publication date: April 13, 2006
    Inventors: Cathryn Mah, Thomas Fraites, Barry Byrne
  • Publication number: 20040193921
    Abstract: A method and system for automatically and transparently providing access to resources associated with a web server which requires authentication. A server is provided for a web browser, which intercepts and responds to authentication requests from web servers. The method and system allows a user to access multiple network resources with a single initial authentication procedure.
    Type: Application
    Filed: August 13, 2003
    Publication date: September 30, 2004
    Inventor: Barry A. Byrne